ASIA PACIFIC HIV DIAGNOSTICS MARKET ANALYSIS
Although the most efficient test results are obtained by Enzyme-Linked Immunosorbent Assay (ELISA) test initially and later by Western blot method, HIV diagnosis can be performed by blood test, saliva test, and viral load test. The ELISA test is an enzyme-linked immunosorbent assay and uses antibodies to identify the substance. The Western blot technique is used to detect anti –HIV antibodies in the human serum sample. According to WHO, the HIV diagnosis includes free –standing sites, testing services in health care facilities, some community-based approaches and HIV self-testing (HIVST).
Market Dynamics
Increasing engagement programs by various government bodies to reduce disease burden of HIV epidemics and growing need for safe blood transfusion and donations in Asia Pacific is expected to drive the HIV diagnostic market size during the forecast period. For instance, India plans to make Pre-exposure prophylaxis (PrEP) available to men who have sex with men (MSM) and transgender women. The Indian Council of Medical Research (ICMR) indicated in November 2018 that it is planning to study the effectiveness of PrEP in high-risk groups.
However, stigma and social ostracism associated with HIV infections and diseases is expected to hinder the timely HIV diagnostics and treatment. Moreover, the fear of being tested positive, discrimination, rejection, and stigma restricts several people from conducting screening voluntarily. The fear of discord in marital relationships is yet another challenge where testing HIV positive is often seen as a case of infidelity. Therefore, these factors are expected to hamper the market growth.
Key features of the study:
- This report provides in-depth analysis of the Asia Pacific HIV diagnostics market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the Asia Pacific HIV diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include, Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche AG, Atomo diagnostics, Siemens Healthineers, Inc., bioLytical Laboratories Inc., MedMira Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Danaher Corporation
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The Asia Pacific HIV diagnostics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for Asia Pacific HIV Diagnostics market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
- Asia Pacific HIV Diagnostics Market, By Product Type:
- Instruments
- Reagents & Kits
- Asia Pacific HIV Diagnostics Market, By Test Type:
- Screening
- Third Generation
- Fourth Generation
- Differentiation & Confirmation Test
- Monitoring Test
- CD4 Tests
- Viral Load Tests
- Asia Pacific HIV Diagnostics Market, By End User:
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Others
- Asia Pacific HIV Diagnostics Market, By Country:
- Japan
- By Product Type:
- Instruments
- Reagents & Kits
- By Test Type:
- Screening
- Third Generation
- Fourth Generation
- Differentiation & Confirmation Test
- Monitoring Test
- CD4 Tests
- Viral Load Tests
- By End User:
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Others
- China
- By Product Type:
- Instruments
- Reagents & Kits
- By Test Type:
- Screening
- Third Generation
- Fourth Generation
- Differentiation & Confirmation Test
- Monitoring Test
- CD4 Tests
- Viral Load Tests
- By End User:
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Others
- South Korea
- By Product Type:
- Instruments
- Reagents & Kits
- By Test Type:
- Screening
- Third Generation
- Fourth Generation
- Differentiation & Confirmation Test
- Monitoring Test
- CD4 Tests
- Viral Load Tests
- By End User:
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Others
- ASEAN
- By Product Type:
- Instruments
- Reagents & Kits
- By Test Type:
- Screening
- Third Generation
- Fourth Generation
- Differentiation & Confirmation Test
- Monitoring Test
- CD4 Tests
- Viral Load Tests
- By End User:
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Others
- Australia
- By Product Type:
- Instruments
- Reagents & Kits
- By Test Type:
- Screening
- Third Generation
- Fourth Generation
- Differentiation & Confirmation Test
- Monitoring Test
- CD4 Tests
- Viral Load Tests
- By End User:
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Others
- India
- By Product Type:
- Instruments
- Reagents & Kits
- By Test Type:
- Screening
- Third Generation
- Fourth Generation
- Differentiation & Confirmation Test
- Monitoring Test
- CD4 Tests
- Viral Load Tests
- By End User:
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Others
- Rest of APAC
- By Product Type:
- Instruments
- Reagents & Kits
- By Test Type:
- Screening
- Third Generation
- Fourth Generation
- Differentiation & Confirmation Test
- Monitoring Test
- CD4 Tests
- Viral Load Tests
- By End User:
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Others
- Company Profiles
- Abbott Laboratories*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merck KGaA
- Hoffmann-La Roche AG
- Atomo Diagnostics
- Siemens Healthineers, Inc.
- bioLytical Laboratories Inc.
- MedMira Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
Request the sample copy of here:
https://www.coherentmarketinsights.com/insight/request-sample/2457
Download the PDF Brochure here:
https://www.coherentmarketinsights.com/insight/request-pdf/2457
Buy now the market research report here:
https://www.coherentmarketinsights.com/insight/buy-now/2457
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.
What we provide:
- Customized Market Research Services
- Industry Analysis Services
- Business Consulting Services
- Market Intelligence Services
- Long term Engagement Model
- Country Specific Analysis
Mr. Shah
Coherent Market Insights Pvt. Ltd.
Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.
Phone: +1-206-701-6702
Email: [email protected]
Source:
https://www.coherentmarketinsights.com/market-insight/asia-pacific-hiv-diagnostics-market-2457